About Arcellx, Inc.
Arcellx is a biotechnology company with one specific mission that is Advance humanity by engineering cell therapies that are safer, more effective and more broadly accessible. The headquarters is in USA.
Arcellx, Inc. timeline
- 2014
- 🏁· approximateFounded
- 2022
- 🔔· approximateInitial public offering on Nasdaq
- 2026
- 🏆Entered the world's top 1,000 companies by market capRanked #783 with $6.7 billion on 8 March 2026, up from #4,574 on 5 January 2024.
Events of Arcellx, Inc. from the company record and our market-cap rankings. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Arcellx, Inc.
- Acquisitions and changes
- No longer listed: ticker ACLX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #1,768 (Dec 2022) · #1,759 (Jul 2023) · #1,322 (Jan 2024) · #22 (Mar 2026)
Mutual funds holding Arcellx, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Nexpoint Merger Arbitrage FundNexPoint Asset Management, L.P. | 751,044 | $0 M | — | <0.01% | +108% | Jun 30, 2026 |
| 🇺🇸 Vy T. Rowe Price Capital Appreciation PortfolioVoya Investments, LLC | 137,328 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 BlackRock Health Sciences Opportunities PortfolioBlackRock Advisors, LLC | 92,964 | $0 M | — | <0.01% | no change | May 29, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 10,685 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 6,200 | $0 M | — | <0.01% | +13% | May 31, 2026 |
| 🇺🇸 The Gabelli ABC FundGabelli Funds, LLC | 6,500 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 TIAA Separate Account VA-1 - Stock Index AccountTeachers Advisors, LLC | 798 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Morningstar Small-Cap ETFBlackRock Fund Advisors | 1,680 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC | 630 | $0 M | — | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 317 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 10 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Markets and events: Arcellx, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2026-04-27 23:50 UTC, code D, resumed 04:00 UTC
Fails to deliver
- : 13,272 shares at $115.07
- : 3 shares at $114.62
- : 4 shares at $114.77
- : 2,424 shares at $114.36
- : 4,816 shares at $114.05
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Where Arcellx, Inc. operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Arcellx, Inc.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
H-1B hiring at Arcellx, Inc.#
2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $211 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Associate ScientistBiochemists and Biophysicists | 1 | — |
| Finance DirectorAccountants and Auditors | 1 | $211 K |
Where: Rockville, MD 1 · Redwood City, CA 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 2 | 2 | $211 K | 2 |
| FY2025 | 12 | 12 | $145 K | 12 |
| FY2024 | 4 | 4 | $133 K | 4 |
| FY2022 | 2 | 2 | $163 K | 2 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Arcellx, Inc.
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Arcellx, Inc.🇺🇸 | $6.7 B | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Market cap:
- Mar 8, 2026 (last known)
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Arcellx, Inc.? Verify and update this profile — free
Show Arcellx, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.